WIXLIB

CDC Strategies to Optimize the Supply of Elastomeric Respirators4/20CDC Strategies to Optimize the Supply of Powered Air Purifying Respirators4/19CDC Strategies to Optimize the Supply of Facemasks4/17CDC Strategies to Optimize the Supply of N95 Respirators4/2CDC Strategies to Optimize the Supply of Ventilators3/20CDC Strategies to Optimize the Supply of Eye Protection3/17CDC Strategies to Optimize the Supply of Isolation Gowns3/17CDC Strategies to Optimize the Supply of Gloves3/17HHS MedicationsHHS CHEMPACK Medications for ICU and Ventilator Care4/2NIOSH PPE StandardsNIOSH National Personal Protective Technology Laboratory (NPPTL) HomepageUpdated 6/8NIOSH Approved N95 Respirators5/12NIOSH Approved Respirator Standards4/15NIOSH Respirator AssessmentsNIOSH Respirator Assessment Results Assessment RequestUpdated 6/5NIOSH Decontaminated Respirator Assessment ResultsUpdated 6/4 NIOSH Beyond Shelf Life Respirator Assessment ResultsAssessment Request Assessment RequestUpdated 6/2NIOSH Healthcare Respiratory Protection ResourcesNIOSH Respiratory Protection Program: Hazard Evaluation and Respirator Selection5/8NIOSH Respiratory Protection Program: Training5/8NIOSH Respiratory Protection Program: Fit Testing5/7NIOSH Respiratory Protection Program: Policies and Procedures5/5NIOSH Respiratory Protection Program: Evaluation5/5NIOSH Respiratory Protection Program: Recordkeeping5/5NIOSH Respiratory Protection Program: Medical Evaluation for Respirator Wearers5/5NIOSH Respiratory Protection Program: Proper Use, Maintenance, Repair, Disposal5/5FDA FAQs & InformationFDA MedWatch: Safety Alerts and Reporting Adverse EventsUpdated 6/7FDA FAQs on Shortages of Surgical Masks and GownsUpdated 6/7FDA Thermal Imaging Systems and COVID-195/13FDA Updated Information for Blood Establishments Regarding COVID-19 Outbreak5/11FDA Medical Glove Conservation Strategies4/27FDA Ventilator FAQs4/27FDA FAQs on 3D Printing of Medical Devices, Accessories, Components, and Parts4/5FDA Temporary Enforcement Policies and GuidanceFDA Policy for Preparation of Alcohol-Based Hand Sanitizer ProductsUpdated 6/1FDA Recent Medical Device Guidance Documents and Enforcement PoliciesUpdated 6/5FDA Policy for Face Masks and Respirators5/26Page 6 of 28

FDA Policy on Pharmacy Drug Compounding for Hospitalized Patients5/21FDA Policy for Certain Drug Compounding for Hospitalized Patients5/21FDA Policy for Imaging Systems4/23FDA Policy for Non-Invasive Fetal and Maternal Monitoring Devices4/23FDA Policy on Pharmacy Repackaging Propofol for Hospitals4/22FDA Policy for Telethermographic Systems4/16FDA Enforcement Policy for Infusion Pumps and Accessories4/5FDA Policy for Gowns, Other Apparel, and Gloves3/30FDA Policy for Ventilators and Accessories and Other Respiratory Devices3/22FDA PPE Emergency Use Authorizations (EUA)FDA PPE EUA Information Page5/27FDA EUA: Stryker VHP Decontamination SystemFactsheet Instructions A B 5/27FDA EUA: Gowns and Other ApparelFDA EUA: STERIS Steam Sterilizers5/22 Factsheet Instructions A BFDA EUA: CAMIC Airway Management 5/21Factsheet A B Instructions A BFDA EAU: Non-NIOSH-Approved Respirators Made in ChinaFDA EUA: Duke Decontamination SystemFDA EUA: Protective Barrier EnclosuresFact Sheet AFDA EUA: Sterilucent Sterilization System FAQs5/7Fact Sheet Instructions A B C List Letter 5/19B 5/1Fact Sheet Instructions A FDA EUA: Stryker STERIZONE N95 Decontamination 5/7Factsheet B4/20Instructions A B4/15FDA EUA: Use of Certain Faceshields4/13FDA EUA: ASP STERRAD for N95 Decontamination FDA EUA: STERIS System for N95 DecontaminationFDA EUA: Battelle Decontamination System Factsheet FactsheetInstructionsInstructions A Instructions AB 4/11B4/9Fact Sheet 3/29FDA EAU: Imported, Non-NIOSH-Approved Respirators3/28FDA EAU: NIOSH-Approved Air Purifying Respirators for in Health Care Settings3/28FDA Ventilator & Medical Device Emergency Use Authorizations (EUA)FDA Ventilator & Medical Device EUA Information PageFDA EUA: Abiomed Right Ventricular Assist CatheterFDA EUA: CLEWICU Predictive Screening SystemFDA EUA: Baxter Prismaflex ST Set CRRTFDA EUA: G. Medical VSMS ECG Patch Factsheet AFactsheet A BInstructions Factsheet AFDA EUA: Eko ECG Low Ejection Fraction ToolFDA EUA: teleCARE IP Nurse Call System FDA EUA: Patient Isolation Transport Unit (PITU) B InstructionsInstructionsB B B 5/205/145/13InstructionsInstructions A B 5/11B5/11Instructions AInstructions A5/295/26Appendix AFactsheet AFactsheet A BFactsheet A BFactsheet AFactsheet A Factsheet A BInstructions A BFDA EUA: Infusion Pumps and AccessoriesFDA EUA: PhysiolGuard ECG-QT Monitor 5/29 B BC5/85/5FDA EUA: List of Ventilators, Tubing & Accessories Authorized per 3/24 EUA5/1FDA EUA: VentFree Respiratory Muscle Stimulator Factsheet A B Instructions A B5/1FDA EUA: Fresenius multiFiltratePRO CRRT Factsheet A B Instructions A B C D EPage 7 of 284/30

FDA EUA: VitalPatch Remote Patient MonitorFDA EUA: Non-Surgical Face Masks Fact Sheet AFDA EUA: Lungpacer DPTS 4/264/24FDA EUA: Hemolung Respiratory Assist DeviceFDA EUA: ExThera EBP DeviceInstructions FAQsFDA EUA: Baxter Healthcare Corporation EBP DeviceFDA EUA: IntelliVue Patient MonitorsB Fact Sheet AFact Sheet A Fact Sheet AFact Sheet A B B B B InstructionsInstructions AInstructions A BBInstructions FDA EUA: B. Braun Space and Outlook PumpsAdditional Info Additional Info4/134/11Additional Info4/10FDA EUA: Terumo BCT and Marker Therapeutics AG EBP DevicesFDA EUA Ventilators, Tubing & Accessories 4/214/14FDA EUA: Synapse Biomedical TransAeris DPTS 4/224/17Additional InfoFDA EUA: CytoSorbents EBP Device4/22Factsheet A B Additional InfoAppendix A Appendix B4/93/24FDA Therapeutics Emergency Use Authorizations (EUA)FDA Therapeutics EUA Information PageFDA EUA: Fresenius Kabi Propoven 2%FDA EUA: Remdesivir EAU Letter 5/28 Factsheet AFact Sheet A B C5/8B5/1FDA EUA: Remdesivir FAQs5/29FDA EUA: Chloroquine and Hydroxychloroquine Factsheet A B C DFDA Drug Safety Communication on the Use of Hydroxychloroquine or ChloroquineFDA Chloroquine and Hydroxychloroquine FAQs4/274/304/8OSHA PPE GuidanceOSHA Enforcement Guidance on Decontamination of Filtering Facepiece RespiratorsOSHA Expanded Temporary Guidance on N95 Fit TestingOSHA Temporary Guidance on N95 Fit Testing4/244/83/14 Back to TopNon-Acute CareNYSDOH Outpatient & Ambulatory Surgery & ProceduresNYSDOH Resumption of Deferred Surgeries & Procedures in ACS, OBS & DATC Settings5/19CDC Outpatient & Ambulatory CareCDC Guidance for Outpatient and Ambulatory Care Settings5/26NYSDOH Nursing Home and Adult Care Facility Staff Testing per E.O. 202.30NYSDOH Directive: Testing of NH and ACF Personnel Deemed Medically Necessary5/19NYSDOH Updated FAQs: NH and ACF Staff Testing Requirements5/19NYSDOH Laboratory Partner List for NH and ACF Staff Testing5/18NYSDOH NH and ACF Staff Testing Certification of Compliance Clarification5/18NYSDOH NH and ACF Staff Testing Certification of Compliance5/15NYSDOH NH and ACF Staff Testing, and Discharge Requirements per E.O. 202.305/11Page 8 of 28

NYSDOH Nursing HomesNYSDOH Nursing Home Cohorting FAQs5/13NYSDOH Nursing Home Assistance and Coordination Center: DAL5/10NYSDOH E.O. 202.18 and 202.19 - NH and ACF Communication Requirements4/19NYSDOH E.O. 202.18 -and 202.19 - Managing NH Resident Deaths4/19NYSDOH Guidance for Managing Decedent Personal Effects in Healthcare Facilities4/19NYSDOH LTCF Infection Prevention and Control Preparedness Checklist4/10NYSDOH Advisory on 1135 Waivers for Nursing Home Feeding Assistants4/7NYSDOH Advisory on 1135 Waivers for Nursing Home Staffing4/4NYSDOH Guidance for Adult Care Facilities and Nursing Homes4/4NYSDOH Guidance on Skilled Nursing Facilities Use of Home Hemodialysis3/21NYSDOH Recommendations to Protect Nursing Home Residents3/20CDC Nursing HomesCDC Key COVID-19 Preparedness Strategies for Long-term Care Facilities5/21CDC Preparing for COVID-19 in NHs: Infection Prevention and Control Guidance5/19CDC Performing Facility-wide SARS-CoV-2 Testing in Nursing Homes5/19CDC Guidance for Testing Nursing Home Residents and Personnel5/19CDC Considerations for Memory Care Units in Long-term Care Facilities5/12CDC Infection Prevention and Control Assessment Tool for Nursing Homes5/8CDC Responding to COVID-19 in Nursing Homes4/30CMS Nursing HomesCMS Nursing Home Reopening Recommendations for State and Local Officials FAQsCMS Letter to Nursing Home Facility Management & Staff5/11CMS Guidance on LTCF Notification Requirements for Suspected/Confirmed COVID-19CMS LTCF Notification Requirements for Suspected/Confirmed COVID-19 CasesCMS LTCF Guidance for Transferring or Discharging ResidentsCMS LTCF Guidance5/18 Memo5/64/194/134/2OSHA Nursing HomesOSHA Nursing Home Worker Safety Alert5/14NYSDOH Adult Care Facilities (ACF)NYSDOH E.O. 202.18 and 202.19 - NH and ACF Communication Requirements4/19NYSDOH ACF Infection Prevention and Control Guidance4/17NYSDOH ACF Infection Prevention and Control Preparedness Checklist4/17NYSDOH Advisory on Hospital Discharges and Admissions to ACFs4/7NYSDOH Guidance for Adult Care Facilities and Nursing Homes4/4NYSDOH Guidance Regarding ACF Operations3/22NYSDOH Home CareNYSDOH Regulatory Relief Home Care Providers4/10NYSDOH Guidance for Home Health Aide Training Programs4/10Page 9 of 28

NYSDOH Guidance for Home Health Care and Hospice3/22NYSDOH DialysisNYSDOH Advisory: COVID-19 Guidance for Dialysis TreatmentNYSDOH Guidance on Skilled Nursing Facilities Use of Home Hemodialysis4/73/21CDC DialysisCDC Special Considerations for Patients on Home Dialysis5/13CDC Interim Guidance for Outpatient Hemodialysis Facilities5/12CDC Outpatient Dialysis Facility Preparedness Assessment Tool4/19CDC Other Providers and SettingsCDC Infection Control Guidance for Blood and Plasma Collection Facilities3/21CDC Guidance for EMS and 911 PSAPs3/10CDC Guidance for Home Care of People Not Requiring Hospitalization for COVID-192/12CMS Other Providers and SettingsCMS Guidance for Infection Control and Prevention in HHAs and RNHCIs4/23CMS Guidance for Infection Control and Prevention in Outpatient Settings3/30CMS Guidance for ASCs Temporarily Enrolling as HospitalsCMS Guidance for Infection Control and Prevention in Dialysis Facilities (Revised)4/33/30 Back to TopExposure, Quarantine and IsolationNYSDOH Guidance for Employees Returning to Work After COVID-19 Infection/Exposure5/31NYSDOH Symptom-Based Strategy to Discontinue Home Isolation for COVID-195/30NYSDOH Contact Tracing Tool for People Being Tested for COVID-195/14NYSDOH Contact Investigation Update for Local Health Departments4/8NYSDOH Mitigation Strategies for Local Health Departments4/7NYSDOH Interim Containment Guidance: Precautionary/Mandatory Quarantine, and Isolation4/1NYSDOH Protocols for Essential Personnel to Return to Work3/31NYSDOH Close or Proximate Contact Guidance3/20NYSDOH Emergency Regulations: Isolation and Quarantine3/9CDC Discontinuation of Home Isolation5/29CDC Healthcare Personnel with Potential Exposure to COVID-195/29CDC Symptom-Based Strategy to Discontinue Isolation for Persons with COVID-195/3CDC Return to Work Criteria for HCP with Confirmed or Suspected COVID-194/30CDC Managing People with COVID-19 in Home Care and Isolation Who Have Pets4/23CDC Evaluating PUIs and Asymptomatic Close Contacts of Confirmed Cases4/10CDC Ending Home Isolation for Immunocompromised Persons with COVID-193/16CDC Guidance for Home Care of People Not Requiring Hospitalization for COVID-192/12 Back to TopPage 10 of 28

TelehealthNYSDOH Medicaid Coverage and Reimbursement Update Webpage5/29NYSDOH Medicaid Comprehensive Telehealth Guidance5/29NYSDOH Telehealth Services During COVID-19 Emergency - FAQs5/1NYSDOH Telephonic and Telehealth Guidance for ADHC Programs3/28NYSDOH Medicaid Coverage and Reimbursement for COVID-19 Services3/27NYSDOH Telehealth Guidance for NHTD/TBI 1915(c) Medicaid Services3/20NYSWCB COVID-19 Telemedicine Emergency Regulations4/20HHS Policy Changes During the COVID-19 Public Health Emergency4/10HHS Telehealth and HIPAA Guidance4/2CMS Telehealth Services Payable under Medicare Physician Fee Schedule4/30CMS Medicare Telehealth Flexibilities4/29CMS Long-Term Care Facility Telehealth and Telemedicine Tool Kit3/27CMS FAQs on Telehealth Services through Private Insurance3/24CMS Telemedicine Toolkit3/20CMS Expanded Telemedicine Fact Sheet - FAQs3/17CMS Medicaid Fee-for-Service Payments for Telehealth State Guidance3/17 Back to TopMedicaid and MedicareNYSDOH COVID-19 Guidance for Medicaid Providers5/29NYSDOH COVID-19 Guidance for Voluntary Plan of Care Schedule Change4/23NYSDOH Medicaid Online Medicaid Provider Enrollment During COVID-194/20NYSDOH Guidance for Medicaid Pharmacies4/6NYSDOH Suspended Health Plan Utilization Review Requirements4/3NYSDOH Medicaid Durable Medical Equipment and Supplies Policy3/28NYSDOH Medicaid Private Duty Nursing Policy3/28NYSDOH Medicaid Coverage and Reimbursement for COVID-19 Services3/27NYSDOH Guidance for Medicaid Transportation Managers and Brokers3/21NYSDOH Guidance for Facilitated Enrollment of the Aged, Blind and Disabled3/21CMS Medicare Fee-for-Service Billing FAQsUpdated 6/2CMS Quality Payment Program Flexibilities5/29CMS Payment for Hospital Alternate Care Sites: Factsheet5/26CMS Medicare Payment for COVID-19 Diagnostic Tests: Guidance5/19CMS Lab Tests Which Medicare Does Not Require a Practitioner Order During the PHE5/12CMS Letter to Clinicians Participating in MIPS4/28CMS CARES ACT Reimbursement Waivers and Implementation Guidance4/27CMS Accelerated and Advanced Payments Fact Sheet4/26CMS Medicaid & CHIP FAQs on CARES ACT Enhanced Federal Funding4/13Page 11 of 28

CMS Final Rule: Policy and Regulatory Revisions in Response to COVID-19 PHE4/6CMS Medicare Provider Enrollment Relief FAQs3/28CMS Exceptions and Extensions for Quality Reporting Requirements3/27CMS Medicare Coverage and Payment Related to COVID-19: Factsheet3/23CMS Exceptions for Quality Measure Reporting3/22 Back to TopFederal Declarations & WaiversHHS Declaration of a Public Health Emergency - Renewal Effective 4/26/204/21HHS Waiver or Modification of Requirements Under §1135 of the Social Security Act3/13HHS Declaration of a Public Health Emergency Effective 1/27/201/31CMS COVID-19 Waivers HomepageUpdated6/5CMS Blanket Waivers for Health Care ProvidersUpdated6/5CMS Blanket Swing Bed Waiver: FAQs5/20CMS Flexibilities for Hospitals5/15CMS Flexibilities for Long Term Care Facilities5/15CMS COVID-19 Regulations & Waivers To Enable Health System Expansion5/4CMS Flexibilities for Physicians and Other Clinicians4/29CMS Flexibilities for Laboratories4/29CMS Burden Relief FAQs for Providers4/23CMS Guidance: Blanket Waivers Under Physician Self-Referral Law (§1877-g)4/21CMS Letter to Clinicians Outlining Regulatory Flexibilities4/7CMS Guidance for Ambulatory Surgical Centers Enrolling as Hospitals4/3CMS Blanket Waivers Under Physician Self-Referral Law (§1877-g)3/30CMS Guidance and 1135 Waivers for Hospitals, CAHs and Psychiatric Hospitals3/30CMS Medicare Provider Enrollment Relief FAQs3/28CMS 1135 Waivers Approved for New York3/26 Back to TopNYS Executive Orders and WaiversExecutive Order 202.36Ed. Law 6530Effective 6/2 - 7/2To allow a questionnaire administered through an asynchronous electronic interfaceor electronic mail that is approved by a physician licensed in the State of New York tobe sufficient to establish a practitioner-patient relationship for purposes of ordering aclinical laboratory test. Back to TopExecutive Order 202.32Extends E.O. 202.23 202.27 until 6/20Effective 5/21 - 6/20Continues suspensions and modifications of laws and directives, not superseded by asubsequent directive, made by E.O. 202.23 through 202.27, for thirty days.Page 12 of 28

NH and ACF Staff TestingIn furtherance of E.O. 202.30 and any extensions thereof, allow clinical laboratoriesto accept and examine specimens for COVID-19 testing, from personnel of nursingPHL 576-b(1); 10 NYCRR 58homes and adult care facilities, as such personnel are defined in E.O. 202.30, without1.8a prescription or order from an authorized ordering source, and to report the resultsof such tests to the appropriate operators and administrators of the nursing home oradult care facility for which the person for whom the test was performed providesservices; provided that, to ensure appropriate follow-up with patients who testpositive for COVID-19, the facility administrator shall contact the local healthdepartment to ensure all facility personnel who test positive are provided appropriateclinical guidance as well as appropriate isolation orders;Physician Testing OrdersEd. Law 6530To allow physicians to order COVID-19 tests, authorized by the FDA for self-collection,without otherwise having an initial physician-patient relationship with the patient. Back to TopExtended Until 6/20 per E.O. 202.32Executive Order 202.31Removes NY On PAUSERestrictions for Phase IIndustries in theFollowing Regions: Finger LakesCentral New YorkMohawk ValleySouthern TierNorth CountryProvisions of E.O. 202.31apply to regions whichsubsequently meetcriteria.Extends All Other of NYOn PAUSE Restrictionsthrough 5/28Effective 5/14 - 6/13E.O. 202.28, which extended the provisions of E.O. 202.3, 202.4, 202.5, 202.6, 202.7,202.8, 202.10, 202.11, 202.13, and 202.14 which each closed or otherwise restrictedpublic or private businesses or places of public accommodation, and which requiredpostponement or cancellation of all non-essential gatherings of individuals of any sizefor any reason (e.g. parties, celebrations, games, meetings or other social events),which together constitute New York On PAUSE, is hereby continued until 11:59 p.m.on May 28, 2020, unless later amended or extended by a future E.O.Provided, however, that effective at 12:01 a.m. on May 15, 2020 that the reductionsand restrictions on the in-person workforce at non-essential businesses or otherentities shall no longer apply to Phase One industries: Construction, Agriculture, Forestry, Fishing and Hunting, Retail (Limited to curbsideor in-store pickup/drop off); Manufacturing and Wholesale Trade; Such businesses or enti

CDC Nursing Home Testing Guidance CDC Performing Facility-wide SARS-CoV-2 Testing in Nursing Homes 5/19 CDC Guidance for Testing Nursing Home Residents and Personnel 5/19 NYSDOH Testing Orders, Specimen Collection & Reporting NYSDOH Updated Interim Guidance: Protocol for COVID-19 Testing per E.O. 202.19 5/31